Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOS | P01100 | 1/20 | 0.69 |
| ▸ | TTR | P02766 | 1/20 | 0.69 |
| ▸ | JUN | P05412 | 1/20 | 0.69 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.69 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.69 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | MMP1 | P03956 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | LDHA | P00338 | 1/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22108693 | 1.00 | FOS (0.69) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL30417396 | 0.88 | FOS (0.69) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL12775269 | 0.88 | FOS (0.69) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL18082680 | 0.87 | LDHA (0.76) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL491190 | 0.87 | LDHA (0.76) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL9781691 | 0.87 | LDHA (0.76) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL27952348 | 0.85 | FOS (0.61) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL12775014 | 0.85 | FOS (0.65) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL2454609 | 0.84 | KDM6B (0.66) | FOSTTRJUNNR3C1HSD17B1 | |
| SCHEMBL31167480 | 0.84 | KDM6B (0.66) | FOSTTRJUNNR3C1HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240100072-A1 | SUBCUTANEOUSLY ADMINISTERED TREATMENTS FOR ADVANCED PARKINSON'S DISEASE | ABBVIE INC. | 2024-03-28 | — | — | US | disclosed |
| US-20100028901-A1 | METHOD FOR DIAGNOSING IN VITRO OR EX VIVO PSYCHIATRIC DISORDERS AND/OR INTESTINAL DYSBIOSES | AURE (FR) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240100072-A1 | SUBCUTANEOUSLY ADMINISTERED TREATMENTS FOR ADVANCED PARKINSON'S DISEASE | SNCA, PARK7, SMN1; SMN2 | FOS 4630/4885TTR 59/4885JUN 4552/4885 |
| US-20100028901-A1 | METHOD FOR DIAGNOSING IN VITRO OR EX VIVO PSYCHIATRIC DISORDERS AND/OR INTESTINAL DYSBIOSES | DBH, CRH, SI | FOS 1195/4885TTR 1490/4885JUN 4292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.